Ticker
MRNA
2 reports from NewsNTech on MRNA, newest first.
Merck and Moderna's melanoma vaccine posts first positive Phase 3 for a personalized mRNA cancer therapy
Regulatory
Aug 20, 2026
Quant funds rocked as Treasury buyback expansion and Moderna rally compound momentum stress
Tech
Aug 20, 2026
← All tickers